Advancing Cardiac Care: How Samsung Ultrasound Empowers Cardiovascular Diagnosis
- solution335
- Sep 24, 2025
- 2 min read
SINGAPORE – August 28, 2025 – Scanmed Technology, the official distributor of Samsung Ultrasound Systems in Singapore, is proud to announce the availability of the Samsung cV-Series, a premium line of ultrasound solutions engineered specifically for cardiac and vascular imaging. With advanced AI tools, quantification technologies, and streamlined workflow features, the cV-Series empowers cardiovascular specialists to deliver more accurate and efficient care.
Cardiovascular disease remains one of the leading health concerns in Singapore, with early detection and precise monitoring playing a critical role in improving patient outcomes. The Samsung cV-Series was designed with these needs in mind, combining cutting-edge image quality with AI-driven diagnostic support to help physicians detect, measure, and track cardiovascular conditions with greater accuracy.
“The cV-Series represents Samsung’s commitment to advancing cardiac imaging through innovation,” said Daniel Soh, Managing Director of Scanmed Technology. “By equipping cardiovascular specialists with high-resolution imaging and AI-based quantification tools, this system enables earlier diagnosis, improved reproducibility, and enhanced workflow efficiency in clinical practice.”
Powered by Crystal Architecture™, the cV-Series delivers exceptional clarity and resolution, making it easier to visualize fine cardiac structures and vascular pathways. Enhanced imaging tools such as HQ-Vision™, ClearVision™, and S-Flow™ ensure precise visualization of blood flow and cardiac anatomy, even in challenging cases.
The cV-Series also integrates specialized AI-powered applications tailored for cardiovascular care, including:
HeartAssist™ – automatically identifies standard echocardiographic views and provides guided measurements.
Strain+™ – quantifies global and segmental left ventricular wall motion for advanced cardiac assessments.
StressEcho™ – streamlines exercise and pharmacological stress testing with automated wall-motion scoring.
AutoIMT+™ – quickly measures carotid intima-media thickness for early vascular disease detection.
ArterialAnalysis™ – assesses vascular stiffness, IMT, and pulse wave velocity for preclinical vascular health evaluation.
These features help cardiovascular specialists improve diagnostic accuracy, reduce inter-observer variability, and save valuable time in busy clinical environments.
With additional tools like SonoSync™ remote collaboration, EzExam+™ customizable protocols, and robust data security measures, the cV-Series is designed to support hospitals and cardiac centers in delivering advanced cardiovascular care while ensuring efficiency and compliance.
“Bringing the cV-Series to Singapore provides cardiologists and vascular specialists with a powerful new solution for diagnosing and managing heart and vascular disease,” Soh added. “It is more than just an ultrasound, it’s a platform built to elevate standards of care in cardiovascular health.”
About Scanmed Technology
Scanmed Technology PTE LTD is a leading medical solutions provider in Singapore, focused on bringing innovative healthcare technologies to the Singapore market. With deep industry experience and a commitment to clinical excellence, Scanmed partners with global innovators to deliver impactful solutions to healthcare professionals.
Find out more:
+65 9093 3196
Comments